Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort

PURPOSE: Immunotherapy has emerged as a novel therapy, while many patients are refractory. Although, several biomarkers have been identified as predictive biomarkers for immunotherapy, such as tumor specific genes, PD-1/PD-L1, tumor mutation burn (TMB), and microsatellite instability (MSI), results...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunbo, Ding, Yan, Zhang, Xuyin, Hua, Keqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283634/
https://www.ncbi.nlm.nih.gov/pubmed/35834061
http://dx.doi.org/10.1007/s12672-022-00528-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283634/
https://www.ncbi.nlm.nih.gov/pubmed/35834061
http://dx.doi.org/10.1007/s12672-022-00528-8

Ejemplares similares